Overview
John Heymach is an Oncologist in Houston, Texas. Dr. Heymach is highly rated in 14 conditions, according to our data. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy.
His clinical research consists of co-authoring 471 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Blue Cross Blue Shield
- Humana
Locations
2130 W Holcombe Blvd, Life Sciences Plaza, Houston, TX 77030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Srdan Verstovsek is an Oncologist and a Hematologist Oncology provider in Houston, Texas. Dr. Verstovsek is highly rated in 28 conditions, according to our data. His top areas of expertise are Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera, Bone Marrow Aspiration, and Bone Marrow Transplant.
MD Anderson
Hagop Kantarjian is an Oncologist and a Hematologist in Houston, Texas. Dr. Kantarjian is highly rated in 48 conditions, according to our data. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Bone Marrow Aspiration.
MD Anderson
Naveen Pemmaraju is an Oncologist and a Hematologist in Houston, Texas. Dr. Pemmaraju is highly rated in 37 conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelofibrosis, Bone Marrow Aspiration, and Bone Marrow Transplant.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- ALK-Positive Non-Small Cell Lung Cancer
- EGFR Positive Lung Cancer
- Lung Adenocarcinoma
- Metastatic Pleural Tumor
- Non-Small Cell Lung Cancer (NSCLC)
- Pleuropulmonary Blastoma
- Advanced
- Adenoid Cystic Carcinoma
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Large-Cell Lung Carcinoma
- Mesothelioma
- Thymic Epithelial Tumor